Jasper Therapeutics (JSPR) News Today $7.04 +0.22 (+3.17%) Closing price 07/3/2025 03:54 PM EasternExtended Trading$6.90 -0.13 (-1.86%) As of 07/3/2025 04:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock JSPR Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Jasper Therapeutics, Inc. (NASDAQ:JSPR) Receives $62.22 Consensus Price Target from AnalystsJune 28, 2025 | americanbankingnews.comJasper Therapeutics, Inc. (NASDAQ:JSPR) Receives Average Rating of "Buy" from BrokeragesJune 25, 2025 | marketbeat.comJasper Therapeutics stock maintains buy rating on positive urticaria dataJune 18, 2025 | investing.comJasper Therapeutics Reports Encouraging Results from SPOTLIGHT Phase 1b/2a Study of Briquilimab for Chronic Inducible UrticariaJune 15, 2025 | nasdaq.comJasper Therapeutics’ SWOT analysis: briquilimab’s potential in CSU stock scrutinizedJune 15, 2025 | investing.comJasper Therapeutics Reports Positive Data from 180mg Cohort in SPOTLIGHT Study of Briquilimab in Chronic Inducible UrticariaJune 14, 2025 | globenewswire.comAnalysts Offer Predictions for JSPR FY2026 EarningsJune 10, 2025 | marketbeat.comJasper Therapeutics Announces Briquilimab Presentations at the European Academy of Allergy and Clinical Immunology (EAACI) Annual CongressJune 3, 2025 | globenewswire.comJasper Therapeutics, Inc. (NASDAQ:JSPR) Given Consensus Recommendation of "Buy" by BrokeragesJune 1, 2025 | marketbeat.comJasper Therapeutics (NASDAQ:JSPR) Will Have To Spend Its Cash WiselyMay 29, 2025 | finance.yahoo.comWoodline Partners LP Decreases Stake in Jasper Therapeutics, Inc. (NASDAQ:JSPR)May 26, 2025 | marketbeat.comJasper Therapeutics, Inc. (JSPR): Analysts See 914% Upside PotentialMay 21, 2025 | insidermonkey.comSoleus Capital Management L.P. Has $31.95 Million Stake in Jasper Therapeutics, Inc. (NASDAQ:JSPR)May 21, 2025 | marketbeat.comJasper Therapeutics to Present at RBC and Jefferies Global Healthcare Conferences on Briquilimab DevelopmentMay 16, 2025 | nasdaq.comJasper Therapeutics (NASDAQ:JSPR) Releases Earnings Results, Misses Expectations By $0.24 EPSMay 14, 2025 | marketbeat.comJasper Therapeutics to Present at Upcoming Investor ConferencesMay 14, 2025 | globenewswire.comJasper Therapeutics, Inc. (NASDAQ:JSPR) Shares Acquired by Integral Health Asset Management LLCMay 14, 2025 | marketbeat.comJasper Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate UpdateMay 12, 2025 | globenewswire.comJasper Therapeutics (JSPR) Expected to Announce Earnings on TuesdayMay 8, 2025 | marketbeat.comJasper Therapeutics, Inc. (NASDAQ:JSPR) Shares Acquired by Braidwell LPMay 8, 2025 | marketbeat.comJasper Therapeutics, Inc. (NASDAQ:JSPR) Receives Consensus Recommendation of "Buy" from AnalystsMay 8, 2025 | marketbeat.comAlly Bridge Group NY LLC Decreases Stock Holdings in Jasper Therapeutics, Inc. (NASDAQ:JSPR)May 4, 2025 | marketbeat.comBoxer Capital Management LLC Buys New Shares in Jasper Therapeutics, Inc. (NASDAQ:JSPR)May 4, 2025 | marketbeat.comT. Rowe Price Investment Management Inc. Makes New $1.76 Million Investment in Jasper Therapeutics, Inc. (NASDAQ:JSPR)April 30, 2025 | marketbeat.comJasper Therapeutics, Inc. (NASDAQ:JSPR) Receives Average Rating of "Buy" from AnalystsApril 13, 2025 | marketbeat.comShort Interest in Jasper Therapeutics, Inc. (NASDAQ:JSPR) Decreases By 19.7%April 1, 2025 | marketbeat.comJasper Therapeutics inks new sales agreement, ends previous dealMarch 21, 2025 | uk.investing.comJasper Therapeutics files $300M mixed securities shelfMarch 19, 2025 | markets.businessinsider.comJasper Therapeutics, Inc. (NASDAQ:JSPR) Short Interest UpdateMarch 19, 2025 | marketbeat.comJasper Therapeutics, Inc. (NASDAQ:JSPR) Given Consensus Recommendation of "Buy" by AnalystsMarch 17, 2025 | marketbeat.comJasper Therapeutics (NASDAQ:JSPR) Earns "Buy" Rating from HC WainwrightMarch 12, 2025 | marketbeat.comFY2025 EPS Estimates for JSPR Raised by Cantor FitzgeraldMarch 7, 2025 | marketbeat.comEquities Analysts Set Expectations for JSPR Q1 EarningsMarch 3, 2025 | marketbeat.comJasper Therapeutics presents updated data from Phase 1b/2a BEACON studyMarch 2, 2025 | msn.comJasper Therapeutics Presents Clinical and Preclinical Briquilimab Data at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual MeetingMarch 1, 2025 | globenewswire.comJasper Therapeutics (NASDAQ:JSPR) Announces Earnings Results, Misses Estimates By $0.42 EPSFebruary 28, 2025 | marketbeat.comJasper Therapeutics Announces Late-Breaking Briquilimab Presentation at the American Academy of Dermatology (AAD) Annual MeetingFebruary 28, 2025 | globenewswire.comJasper Therapeutics Reports Promising Clinical ProgressFebruary 27, 2025 | tipranks.comJasper Therapeutics reports Q4 EPS ($1.62), consensus ($1.23)February 27, 2025 | markets.businessinsider.comJasper Therapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Corporate UpdateFebruary 27, 2025 | globenewswire.comJasper Therapeutics to Present at Upcoming March Investor ConferencesFebruary 25, 2025 | globenewswire.comJasper Therapeutics (JSPR) to Release Quarterly Earnings on MondayFebruary 24, 2025 | marketbeat.comJasper Therapeutics, Inc. (NASDAQ:JSPR) Short Interest Down 15.5% in JanuaryFebruary 17, 2025 | marketbeat.comUBS Initiates Coverage of Jasper Therapeutics (JSPR) with Buy RecommendationFebruary 13, 2025 | msn.comJasper Therapeutics initiated with a Buy at UBSFebruary 13, 2025 | markets.businessinsider.comUBS Group Begins Coverage on Jasper Therapeutics (NASDAQ:JSPR)February 13, 2025 | marketbeat.comJasper Therapeutics Announces Briquilimab Presentations at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual MeetingFebruary 10, 2025 | globenewswire.comJasper Therapeutics to Present at the Oppenheimer Healthcare Life Sciences ConferenceFebruary 4, 2025 | globenewswire.comAnalysts Offer Predictions for JSPR FY2025 EarningsJanuary 22, 2025 | marketbeat.comShort Interest in Jasper Therapeutics, Inc. (NASDAQ:JSPR) Grows By 12.1%January 18, 2025 | marketbeat.com Get Jasper Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for JSPR and its competitors with MarketBeat's FREE daily newsletter. Email Address JSPR Media Mentions By Week JSPR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. JSPR News Sentiment▼0.000.54▲Average Medical News Sentiment JSPR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. JSPR Articles This Week▼12▲JSPR Articles Average Week Get Jasper Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for JSPR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Aquestive Therapeutics News Prothena News Terns Pharmaceuticals News Prime Medicine News Humacyte News SNDL News Heron Therapeutics News Aura Biosciences News Altimmune News Citius Oncology News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:JSPR) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jasper Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Jasper Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free JSPR Stock Alerts